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INTRODUCTION
Hearing loss is relatively common in the human population. Se-
vere to profound sensorineural hearing loss (SNHL) is estimated 
to occur at approximately 1 in 1,000 births and the cause is ge-
netic in 50% of all cases (1). Approximately 70% of congenital 
cases associated with genetic factors are classified as nonsyn-
dromic. For the remaining 30%, one out of more than 400 forms 
of syndromic deafness can be diagnosed because of associated 
clinical findings. Eighty percent of cases of nonsydromic hearing 
loss is inherited through an autosomal recessive fashion and 
other cases are inherited in an autosomal dominant, X-linked, 
or mitochondrial pattern (2).
  Genetic hearing loss is a highly heterogeneous disorder, in 
which a number of genes can cause the same phenotype, espe-
cially in nonsyndromic hearing loss (NSHL). Today, the chromo-
somal locations for NSHL are known for 50 dominant loci with 
24 of the genes identified; and for 79 recessive loci with 40 of 
the genes found (3). In spite of this large genetic heterogeneity, 
mutations in SLC26A4 and GJB2 genes are responsible for ma-
jor etiologies of the genetic hearing loss among Koreans (4-6). 
  GJB2 encodes connexin 26, a gap junction protein. Gap junc-
tions are believed to play a role in recycling potassium ions back 
to the endolymph of the cochlear duct after stimulation of the 
sensory hair cells. The loss of connexin 26 would be expected to 
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disrupt this potassium ion flow, thereby leading to hearing loss. 
Mutations in GJB2, which is located on chromosome 13q11-12, 
accounts for 20 to 50% of all recessive NSHL based on ethnic 
background (7, 8).
  The second most common gene in which mutations have been 
reported in hearing-impaired patients is the SLC26A4 gene. 
Overall, SLC26A4 gene mutations associated with an enlarged 
vestibular aqueduct (EVA) may account for 5% to 10% of pa-
tients with prelingual hearing loss (6, 9). The SLC26A4 gene is 
located on chromosome 7q22-q31 and encodes a chloride-iodide 
transporter that is expressed in the thyroid, inner ear, and kidney. 
The gene has 21 exons. SLC26A4 mutations can cause both Pen-
dred syndrome and recessive NSHL (DFNB4), two autosomal 
recessive disorders that share hearing loss associated with EVA 
or Mondini dysplasia as the common feature. The clinical distinc-
tion between DFNB4 and Pendred syndrome can be difficult to 
make because the goiter phenotype is variably penetrant and 
may not be apparent until adolescence or adult life (10). 
  The purpose of this study is to investigate the genetic cause of 
deafness in Korean cochlear implantees by performing the ge-
netic screening of SLC26A4 and GJB2 genes. These genetic 
screenings can provide direct clues about the pathogenesis of 
hearing loss for certain cochlear implant (CI) patients. 
MATERIALS AND METHODS
Recruitment of subjects
The study cohort comprised 421 unrelated Korean probands with 
sporadic or familial SNHL and who had received CI surgery at 
Soree Ear Clinic between July 2002 to December 2010. For pa-
tients with bilaterally severe to profound SNHL and without 
previously known causes of hearing loss (e.g., taken ototoxic 
drugs, or had a history of meningitis, trauma), we ordered them 
to screen for genetic causes before CI surgery. Except for those 
patients who refused to take the test, 230 patients were screened. 
Among 230 patients who received the genetic screening test, 
210 (91.3%) were prelingual deafness. The age range of the 230 
patients was 1.8 to 63 years (median age, 3 years; mean age, 8.9 
years).
  Preoperative auditory assessment with auditory brainstem re-
sponse, or pure-tone audiometry was carried out for all CI can-
didates. All patients demonstrated severe to profound hearing 
loss. We obtained written, informed consent from adult subjects, 
and parents of minor subjects. 
Mutation screening
We analyzed SLC26A4 for the patients who showed unilateral 
or bilateral EVA on their temporal bone imaging, obtained using 
high-resolution computed tomography or magnetic resonance 
imaging. EVA was defined as a diameter >1.5 mm at the mid-
point of the course of the vestibular aqueduct between the pos-
terior cranial fossa and the vestibule of the inner ear. We screened 
56 patients for SLC26A4. We did not separate Pendred syndrome 
from DFNB4. For the other 174 patients who did not show EVA, 
GJB2 gene was sequenced. 
  Mutation screening included both exons of GJB2 (performed 
by sequencing the entire gene) and five hot point mutations 
(H723R, IVS7-2A>G, IVS9+3A>G, M147V, and 365insT) of 
SLC26A4 found in our subjects. We did not analyze all SLC26A4 
exons in all the probands owing to limitations of DNA sample 
volumes and the expense of nucleotide sequencing.
RESULTS
SLC26A4 screening group
For the 56 SLC26A4 patients, 32 probands (57.1%) had two 
pathogenic recessive mutations in SLC26A4. Fourteen probands 
were homozygous for the H723R mutation, 4 probands were 
homozygous for the IVS7-2A>G, and 14 probands were com-
pound heterozygotes, confirming SLC26A4-related hearing im-
pairment. A single recessive SLC26A4 mutation was identified 
in 14 probands with 2 variants in SLC26A4. Five probands had 
no SLC26A4 mutation (Table 1).
  Among the five hot point SLC26A4 mutations, H723R and 
IVS7-2A>G were by far the most frequent and accounted for 
60.2% (47/78) and 30.7% (24/78) of the mutated alleles, respec-
tively. This was followed by IVS9+3A>G (2.5%), and 365insT 
(1.2%) (Table 2). Twelve (21.4%) of the 56 probands with EVA 
had an incomplete cochlear partition. 
GJB2 screening group
For the 174 GJB2 patients, 20 probands (11.5%) had two patho-
genic recessive mutations in GJB2. Gene sequencing demon-
strated that 12 probands were homozygous 235delC mutation, 1 
proband was homozygous R143W mutation, and 7 probands 
were compound heterozygote mutations. One hundred twenty-








Allele 1 Allele 2 + - Pre Post
H723R H723R 14 10 4 14 0 5
IVS7-2 A>G IVS7-2 A>G 4 1 3 4 0
H723R IVS7-2 A>G 9 3 6 8 1 1
H723R T410M 1 0 1 1 0
H723R L676Q 1 0 1 1
IVS7-2A>G IVS9+3A>G 1 0 1 1 0 1
IVS9+3A>G IVS14-1G>A 1 0 1 1 0
365insT IVS15+5G>A 1 0 1 1 0
H723R Wild type 8 1 7 7 1 3
IVS7-2 A>G Wild type 6 2 4 5 1 2S12    Clinical and Experimental Otorhinolaryngology   Vol. 5, Suppl 1: S10-S13, April 2012
nine probands had no GJB2 mutation. A single recessive GJB2 
mutation was identified in 17 probands with 7 variants (Table 3).
  The most common mutation was 235deC, accounting for 
43.0% of the mutant alleles in GJB2 mutations. This was fol-
lowed by V27I (15.2%), E114G (9.2%), 299-300delAT (8.3%), 
and R143W (5.5%) (Table 2).
DISCUSSION
Molecular genetic testing offers a new tool to determine the ge-
netic causes of a patient’s hearing loss, and its availability is rap-
idly growing. However, because of the extreme heterogeneity of 
hereditary hearing loss, screening for mutations in all genes 
known to be associated with hearing loss is impractical. In the 
present study, we performed the genetic screening of SLC26A4 
and GJB2 genes, responsible for the major etiologies of heredi-
tary hearing loss among Koreans. A definitive genetic diagnosis 
was made in 52 (22.6%) of the 230 CI patients, including 32 
(13.9%) with two pathogenic mutated SLC26A4 alleles and 20 
(8.7%) with two pathogenic mutated GJB2 alleles. 
  SLC26A4 mutations are causative in two autosomal recessive 
disorders, Pendred syndrome and DFNB4. Pendred syndrome is 
characterized by congenital SNHL and goiter. We did not differ-
entiate Pendred syndrome from DFNB4 because goiter usually 
develops during the second decade of life and most of our cases 
were patients younger than 10-years-old. 
  According to Park et al. (5, 6), 23 (96%) of 24 probands with 
SLC26A4 mutations had at least one of the five recurrent muta-
tions (H723R, IVS7-2A>G, IVS9+3A>G, M147V, or 365insT) 
among Koreans. As such, we screened for these five mutations. 
  The prevalence of SLC26A4 biallelic mutations in our series 
of 56 patients was 57.5% (32/56 patients) and prevalence of 
monoallelic mutation was 25% (14/56 patients). According to 
Tsukamoto et al. (11), one or two pathogenic mutations was 
found in 90% of Pendred families, and in 78.1% of families with 
DFNB4 in 32 deaf patients with EVA. Our fndings are similar. 
  The H723R was the most common form of mutation in 47 of 
78 (60.2%) mutated alleles. The next frequent type of mutation 
was IVS7-2A>G, accounting for 24 of 78 (30.7%) mutated al-
leles. Also in the other East Asian series, H723R and IVS7-2A>G 
were the most common mutations (11, 12). By contrast, the mu-
tations, IVS8+1G>A, L236P, and T416P, accounted for nearly 
half of all SLC26A4 mutation alleles among Caucasians (13).
  Fourteen patients with EVA had one detectable SLC26A4 
mutation. It is possible that these are apparent heterozygotes, or 
have SLC26A4 mutations that were not detected by our experi-
mental methodology. Radiologic findings of EVA suggest it is 
closely related to more than one mutation of SLC26A4 (82.1%). 
  Up to 50% of the autosomal recessive NSHL is associated 
with GJB2 mutations in certain western populations (14, 15), 
whereas GJB2 mutations only account for 20-30% among the 
Japanese (16, 17). In this study, the prevalence of GJB2 biallelic 
mutations of 174 patients was 11.5% (20/174 patients). In addi-
tion, a previous report among Korean NSHL indicated that GJB2 
mutations accounted for only 8.2% (4). These findings suggest 
that different types of deaf gene mutations affect variably accord-
ing to ethnic background. 
  To date, more than 150 different variants have been reported 
in the GJB2 gene (18). In this study, the most common GJB2 
mutation was 235delC, accounting for 31 of 72 (43.0%) mutat-
ed alleles. In other Korean and Japanese studies, 235delC was 
the most prevalent (4, 16, 17). The 235delC mutation results in 
premature termination at codon 81 and a significant loss of 
function of the Connexin26 protein. Many mutations are recog-
nized to be associated with ethnic background. The 167delT is 
the most common connexin26 mutation among Ashkenazi Jews 
(19) and the R143W mutation is most prevalent in Ghana, West 





Onset Inner ear 
anomaly
Allele 1 Allele 2 + - Pre Post
235delC 235delC 12 7 5 12 0
R143W R143W 1 0 1 1 0
235delC 299-300delAT 3 0 3 3 0
235delC R143W 1 0 1 1 0
R143W 299-300delAT 1 0 1 1 0
G45E 504-512insAACG 1 1 0 1 0
V27I T123N 1 0 1 1 0 1
V37I I203T 1 0 1 1 0
V27I E114G 7 2 5 3 4 2
235delC Wild type 3 1 2 3 0
V27I Wild type 3 3 0 2 1 1
F191L Wild type 1 0 1 1 0
299-300delAT Wild type 2 0 2 2 0
I203T Wild type 5 1 4 4 1
R75Q Wild type 1 1 0 1 0
N54I Wild type 1 1 0 1 0
Table 2. Allele frequency of SLC26A4 and GJB2 variations in Korean 
cochlear implantees
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Africa (20). The 35delG mutation is most frequent in a majority 
of the Caucasian populations and may account for up to 70% 
of all GJB2 mutations (7, 8). However, there is no 35delG muta-
tion in this study. Based on a previous study, there were only 2 
heterozygotes among 147 Korean patients with NSHL for the 
35delG mutation (4).
  The next frequent variants were V27I and E114G, accounting 
for 12 of 73 (16.4%) and 7 of 73 (9.6%) variant alleles, respec-
tively. The V27I and E114G variants are commonly found in the 
East Asian population. They are frequently found within the nor-
mal control population, and are considered a benign polymor-
phism (5, 17). We did not count V27I and E114G as pathologic 
mutations. 
  More than 90% of children with congenital profound hearing 
loss are born from parents with normal hearing, while the remain-
ing 10% or less are born from deaf parents (21). Once a patient 
has been formally diagnosed with hearing loss and appropriate 
interventions have been implemented, clinical efforts are then 
directed toward finding the cause of the hearing loss. At the 
same time, whole genome sequencing to find the causative mu-
tation is impractical. In this study, based on sequencing the GJB2 
and SLC26A4 five hot point mutations, we were able to explain 
22.6% of the causes of SNHL among deaf patients in. Identifi-
cation of causative mutations can significantly help to provide 
adequate genetic counseling, which is primarily concerned with 
the planning of pregnancy and delivery with information related 
to a recurrence risk. 
  From this genetic screening, we can explain the genetic causes 
of SNHL to deaf patients in 22.6% of all cases (52/230), suggest-
ing the need for a routine genetic assessment. SLC26A4 is the 
most frequent causative gene in Korean cochlear implant patients. 
GJB2 is also a second major contributor of deafness. The EVA is 
closely related to the mutation of SLC26A4. As our understand-
ing of the molecular basis of hearing improves, a significant per-
centage of hearing loss that is presently idiopathic will likely be 
found to have a genetic basis. Continuous studies are needed to 
identify new genes that can cause hearing loss to cochlear im-
plant patients in Korea.
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